Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Mast cells promote homeostasis by limiting endothelin-1-induced toxicity

Abstract

Endothelin-1 (ET-1) is a 21-amino-acid peptide, derived from vascular endothelial cells, with potent vasoconstrictor activity1. ET-1 has been implicated in diverse physiological or pathological processes2,3, including the vascular changes associated with sepsis2,3,4,5. However, the factors that regulate ET-1-associated toxicity during bacterial infections, or in other settings, are not fully understood2,3,4,5. Both the pathology associated with certain allergic and autoimmune disorders6,7, and optimal host defence against bacterial and parasitic infections8,9,10 are mediated by mast cells. In vitro, mast cells can produce ET-1 (ref. 11), undergo ET-1-dependent and endothelin-A receptor (ETA)-dependent activation12,13, and release proteases that degrade ET-1 (ref. 14). Although the potential relationships between mast cells and the ET-1 system thus may be complex, the importance of interactions between ET-1 and mast cells in vivo is obscure. Here we show that ETA-dependent mast-cell activation can diminish both ET-1 levels and ET-1-induced pathology in vivo, and also can contribute to optimal survival during acute bacterial peritonitis. These findings identify a new biological function for mast cells: promotion of homeostasis by limiting the toxicity associated with an endogenous mediator.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mast cells protect mice from morbidity and mortality after the i.p. injection of ET-1.
Figure 2: Chymase contributes to the ability of mast cells to degrade ET-1 in vitro and in vivo.
Figure 3: Genetic evidence that ETA expression contributes to the ability of PMCs to degranulate and to reduce the levels and toxicity of ET-1 in vivo.
Figure 4: Mast-cell expression of ETA promotes survival in CLP.

Similar content being viewed by others

References

  1. Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415 (1988)

    Article  ADS  CAS  Google Scholar 

  2. Wanecek, M., Weitzberg, E., Rudehill, A. & Oldner, A. The endothelin system in septic and endotoxin shock. Eur. J. Pharmacol. 407, 1–15 (2000)

    Article  CAS  Google Scholar 

  3. Kedzierski, R. M. & Yanagisawa, M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41, 851–876 (2001)

    Article  CAS  Google Scholar 

  4. Szalay, L., Kaszaki, J., Nagy, S. & Boros, M. The role of endothelin-1 in circulatory changes during hypodynamic sepsis in the rat. Shock 10, 123–128 (1998)

    Article  CAS  Google Scholar 

  5. Ornan, D. A., Chaudry, I. H. & Wang, P. The dissociation between upregulated endothelins and hemodynamic responses during polymicrobial sepsis. Biochim. Biophys. Acta 1501, 211–218 (2000)

    Article  CAS  Google Scholar 

  6. Kawakami, T. & Galli, S. J. Regulation of mast-cell and basophil function and survival by IgE. Nature Rev. Immunol. 2, 773–786 (2002)

    Article  CAS  Google Scholar 

  7. Benoist, C. & Mathis, D. Mast cells in autoimmune disease. Nature 420, 875–878 (2002)

    Article  ADS  CAS  Google Scholar 

  8. Echtenacher, B., Männel, D. N. & Hültner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75–77 (1996)

    Article  ADS  CAS  Google Scholar 

  9. Malaviya, R., Ikeda, T., Ross, E. & Abraham, S. N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature 381, 77–80 (1996)

    Article  ADS  CAS  Google Scholar 

  10. Galli, S. J., Chatterjea, D. & Tsai, M. in The Innate Immune Response to Infection (ed. Gordon, S.) 111–132 (ASM, Berlin, 2004)

    Google Scholar 

  11. Ehrenreich, H. et al. Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. New Biol. 4, 147–156 (1992)

    CAS  PubMed  Google Scholar 

  12. Yamamura, H., Nabe, T., Kohno, S. & Ohata, K. Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur. J. Pharmacol. 265, 9–15 (1994)

    Article  CAS  Google Scholar 

  13. Yamamura, H., Nabe, T., Kohno, S. & Ohata, K. Mechanism of histamine release by endothelin-1 distinct from that by antigen in mouse bone marrow-derived mast cells. Eur. J. Pharmacol. 288, 269–275 (1995)

    Article  CAS  Google Scholar 

  14. Metsärinne, K. P. et al. Activated mast cells increase the level of endothelin-1 mRNA in cocultured endothelial cells and degrade the secreted peptide. Arterioscler. Thromb. Vasc. Biol. 22, 268–273 (2002)

    Article  Google Scholar 

  15. Kitamura, Y., Go, S. & Hatanaka, K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52, 447–452 (1978)

    CAS  PubMed  Google Scholar 

  16. Galli, S. J., Zsebo, K. M. & Geissler, E. N. The kit ligand, stem cell factor. Adv. Immunol. 55, 1–96 (1994)

    CAS  PubMed  Google Scholar 

  17. Tsai, M., Tam, S. Y., Wedemeyer, J. & Galli, S. J. Mast cells derived from embryonic stem cells: a model system for studying the effects of genetic manipulations on mast cell development, phenotype, and function in vitro and in vivo. Int. J. Hematol. 75, 345–349 (2002)

    Article  CAS  Google Scholar 

  18. Nakano, T. et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer to genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue and mucosal mast cells. J. Exp. Med. 162, 1025–1043 (1985)

    Article  CAS  Google Scholar 

  19. Maurer, M. et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J. Exp. Med. 188, 2343–2348 (1998)

    Article  CAS  Google Scholar 

  20. Boesiger, J. et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fcɛ receptor I expression. J. Exp. Med. 188, 1135–1145 (1998)

    Article  CAS  Google Scholar 

  21. Maguire, J. J., Kuc, R. E. & Davenport, A. P. Vasoconstrictor activity of novel endothelin peptide, ET-1(1–31), in human mammary and coronary arteries in vitro. Br. J. Pharmacol. 134, 1360–1366 (2001)

    Article  CAS  Google Scholar 

  22. Opgenorth, T. J. Endothelin receptor antagonism. Adv. Pharmacol. 33, 1–64 (1995)

    Article  CAS  Google Scholar 

  23. Clouthier, D. E., Williams, S. C., Hammer, R. E., Richardson, J. A. & Yanagisawa, M. Cell-autonomous and nonautonomous actions of endothelin-A receptor signaling in craniofacial and cardiovascular development. Dev. Biol. 261, 506–519 (2003)

    Article  CAS  Google Scholar 

  24. Tsai, M. et al. In vivo immunological function of mast cells derived from embryonic stem cells: an approach for the rapid analysis of even embryonic lethal mutations in adult mice in vivo. Proc. Natl Acad. Sci. USA 97, 9186–9190 (2000)

    Article  ADS  CAS  Google Scholar 

  25. Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J. & Carroll, M. C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390, 172–175 (1997)

    Article  ADS  CAS  Google Scholar 

  26. Ahn, G. Y. et al. The expression of endothelin-1 and its binding sites in mouse skin increased after ultraviolet B irradiation or local injection of tumor necrosis factor alpha. J. Dermatol. 25, 78–84 (1998)

    Article  CAS  Google Scholar 

  27. Sugiura, M., Inagami, T. & Kon, V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun. 161, 1220–1227 (1989)

    Article  CAS  Google Scholar 

  28. Lundblad, R. & Giercksky, K. E. Endothelin concentrations in experimental sepsis: profiles of big endothelin and endothelin 1–21 in lethal peritonitis in rats. Eur. J. Surg. 161, 9–16 (1995)

    CAS  PubMed  Google Scholar 

  29. Boros, M., Szalay, L. & Kaszaki, J. Endothelin-1 induces mucosal mast cell degranulation and tissue injury via ETA receptors. Clin. Sci. (Lond.) 103(suppl. 48), 31S–34S (2002)

    Article  CAS  Google Scholar 

  30. Higginbotham, R. D. Mast cells and local resistance to Russell's viper venom. J. Immunol. 95, 867–875 (1965)

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank R. Parker of the Biometrics Center of the Beth Israel Deaconess Medical Center for consultation regarding the statistical analysis of the data, S. Fish, L. Fox, M. Liebersbach and A. Xu for technical assistance, M.-H. Jouvin for discussions and critical reading of the manuscript, and R. Paus for supporting M. Metz. This work was supported by United States Public Health Science Grants (to S.J.G.), by grants of the Deutsche Forschungsgemeinschaft (to M. Maurer, J.W. and M. Metz), and by a grant of the Boehringer Ingelheim Fonds (to M. Metz).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen J. Galli.

Ethics declarations

Competing interests

The authors declare that they have no competing financial interests.

Supplementary information

Supplementary Figure 1

ET-1, but not a scrambled peptide, induces hypothermia in mast cell-deficient KitW/KitW-v mice. (PDF 17 kb)

Supplementary Figure 2

Co-incubation with mast cells ex vivo reduces the toxicity of ET-1 in vivo. (PDF 18 kb)

Supplementary Figure 3

Mast cells degrade ET-1 in vitro in a time- and dose-dependent manner. (PDF 40 kb)

Supplementary Figure 4

ET-1 induced degranulation. (PDF 52 kb)

Supplementary Figure 5

Pharmacological evidence that the ability of peritoneal mast cells to reduce the toxicity of ET-1 reflects their expression of ETA. (PDF 23 kb)

Supplementary Figure 6

Extent of PMC degranulation in Kit+/+ mice. (PDF 10 kb)

Supplementary Figure 7

In aperitoneal levels of endogenous ET-1 in female Kit+/+ mice.tr (PDF 11 kb)

Supplementary Figure 8

Pharmacological evidence that ET-1 contributes to mortality after CLP via ETB. (PDF 18 kb)

Supplementary Figure Legends (DOC 26 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maurer, M., Wedemeyer, J., Metz, M. et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 432, 512–516 (2004). https://doi.org/10.1038/nature03085

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature03085

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing